Screening Women to Prevent Anal Cancer: Who and How?
August 28, 4:00 - 5:00 PM (Eastern)
The incidence of anal cancer in women has doubled over the past two decades as a result of anal HPV. Anal HPV infections in women are quite common, in fact, HPV is more commonly detected in the anus than in the cervix. Women with anal cancer often feel highly stigmatized, even though anal HPV infections may occur in the absence of a history of anal sex. This webinar will review the epidemiology of anal HPV and anal cancer in women, will describe the assessment for anal cancer that can be incorporated into an annual exam, and will review prevention strategies, including the detection of anal cancer precursors, which when treated may prevent progression to anal cancer.
Elizabeth Stier, MD
Elizabeth Stier is an associate professor of Obstetrics and Gynecology at Boston University School of Medicine and vice chair of the HPV working group of the NCI sponsored AIDS Malignancy Consortium. She is a clinical researcher with a particular interest in the prevention of anogenital HPV-associated cancers in HIV-positive men and women.
ASCCP Members: FREE
This activity is intended for physicians, physician assistants, midwives, nurse practitioners, nurses working in obstetrics and gynecology, gynecology oncology, oncology, internal medicine, family medicine and general practice.
Upon completion of this educational activity, participants should be able to:
- Identify who is at increased risk for anal cancer;
- Analyze anal HPV in women and in anal cancer;
- Assess for anal cancer with history and physical exam – the perianus and digital anal rectal exam (DARE);
- Explain other anal cancer screening modalities such as anal cytology/HPV testing/high resolution anoscopy.
Continuing Medical Education (CME)
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)TM
ASCCP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As an accredited provider of CME credit, ASCCP has implemented a process to ensure that anyone who is in a position to affect the content of an educational activity has disclosed all relevant financial relationships with any commercial interest. Any conflicts of interest have been resolved by ASCCP prior to the activity.
The following person(s) disclosed relevant financial relationships:
- P. Patricia Cason, MS, FNP-BC – Education Committee Chair, Content Reviewer – Merck (Consultant, Advisory Board, Trainer, Speaker); Teva (Consultant, Advisory Board, Trainer, Speaker); ContraMed (Consultant, Advisory Board, Trainer); Medicines 360 (Trainer, Speaker); CooperSurgical (Consultant, Advisory Board).
The following person(s) disclosed no relevant financial relationships:
- Elizabeth Stier, MD - Author, Faculty
- Peter F. Schnatz, DO - Education Committee Co-Chair
- Christina Arnold - Staff
- Kerry Curtis - Staff
- Cari Price- Staff
- Alisha Yocum- Staff
This webinar is partially supported by an independent education grant from BD Diagnostics.
Registration has now closed.
If you have already registered, you may access the webinar at the time of the event by clicking here.